Business Context and Reporting Period
This Form 8-K Current Report was filed by Croff Enterprises, Inc. on August 14, 2009. The filing reports significant changes to the Company's Board of Directors and executive leadership. Note: The request metadata references "Therapeuticsmd, Inc.", but the source document explicitly identifies the registrant as Croff Enterprises, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or pro forma financial information.
Material Changes
On August 14, 2009, the Company executed the following changes:
- Board of Directors: Sky Kelley resigned as a director. Robert Cambridge and Charles Richardson were elected as new directors.
- Executive Officers: Sky Kelley resigned as President and Chief Executive Officer. Robert Cambridge was appointed as the new President and Chief Executive Officer. Donald R. Mastropietro was appointed to hold additional offices.
Updated Leadership Roster:
- Directors: Robert Cambridge, Andrew Golden, Charles Richardson, Kimberly Sarubbi, Robin Tjon.
- Officers: Robert Cambridge (President and CEO), Donald R. Mastropietro (CFO, VP Finance, Treasurer), Robin Tjon (Secretary).
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors. The document includes standard legal disclosures confirming that none of the new or continuing officers and directors have been subject to bankruptcy, criminal convictions, or securities law violations in the past five years.
Investor Verification Checklist
- Verify the correct registrant name (Croff Enterprises, Inc.) versus the metadata reference (Therapeuticsmd, Inc.).
- Confirm the effective date of the leadership transition (August 14, 2009).
- Review the biographical backgrounds of new directors Robert Cambridge and Charles Richardson for relevant industry experience.
- Check subsequent filings for any financial impact resulting from the change in executive management.